FR2429021A1 - Composition pharmaceutique utile dans le traitement de diverses maladies par action sur le systeme reticuloendothelial et application de cette composition au traitement de tumeurs malignes en therapeutique humaine - Google Patents
Composition pharmaceutique utile dans le traitement de diverses maladies par action sur le systeme reticuloendothelial et application de cette composition au traitement de tumeurs malignes en therapeutique humaineInfo
- Publication number
- FR2429021A1 FR2429021A1 FR7818346A FR7818346A FR2429021A1 FR 2429021 A1 FR2429021 A1 FR 2429021A1 FR 7818346 A FR7818346 A FR 7818346A FR 7818346 A FR7818346 A FR 7818346A FR 2429021 A1 FR2429021 A1 FR 2429021A1
- Authority
- FR
- France
- Prior art keywords
- glycine
- edta
- glycerol
- ascorbic acid
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 title abstract 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title abstract 4
- 206010028980 Neoplasm Diseases 0.000 title abstract 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 title abstract 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 title abstract 3
- 229960005070 ascorbic acid Drugs 0.000 title abstract 2
- 235000010323 ascorbic acid Nutrition 0.000 title abstract 2
- 239000011668 ascorbic acid Substances 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 title 1
- 239000004471 Glycine Substances 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940095064 tartrate Drugs 0.000 title 1
- 235000013619 trace mineral Nutrition 0.000 title 1
- 239000011573 trace mineral Substances 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 3
- 230000007935 neutral effect Effects 0.000 abstract 3
- 229960001484 edetic acid Drugs 0.000 abstract 2
- 230000002349 favourable effect Effects 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 201000004384 Alopecia Diseases 0.000 abstract 1
- 206010028813 Nausea Diseases 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 208000007502 anemia Diseases 0.000 abstract 1
- 229910052796 boron Inorganic materials 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 229910052802 copper Inorganic materials 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 206010016256 fatigue Diseases 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 208000024963 hair loss Diseases 0.000 abstract 1
- 230000003676 hair loss Effects 0.000 abstract 1
- 206010022437 insomnia Diseases 0.000 abstract 1
- 229910052742 iron Inorganic materials 0.000 abstract 1
- 229910052749 magnesium Inorganic materials 0.000 abstract 1
- 229910052748 manganese Inorganic materials 0.000 abstract 1
- 229910052750 molybdenum Inorganic materials 0.000 abstract 1
- 230000008693 nausea Effects 0.000 abstract 1
- 229910052759 nickel Inorganic materials 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 229910052720 vanadium Inorganic materials 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 229910052725 zinc Inorganic materials 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Composition douée de propriétés thérapeutiques. Composition comprenant un mélange de composés de B, F, Mg, V, Mn, Fe, Co, Ni, Cu, Zn et Mo qui ne précipitent pas les uns avec les autres, ni avec les autres composants de la composition, de la glycine, de la glycérine, de l'acide ascorbique, du sel disodique de 2,4,5,7-tétrahalofluorescéine, le sel disodique de l'acide éthylènediaminetétracétique et du tartrate double de sodium et de potassium, associes à de l'eau et éventuellement à d'autres véhicules, diluants et/ou additifs. Application au traitement des maladies tumorales chez l'homme.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7818346A FR2429021A1 (fr) | 1978-06-20 | 1978-06-20 | Composition pharmaceutique utile dans le traitement de diverses maladies par action sur le systeme reticuloendothelial et application de cette composition au traitement de tumeurs malignes en therapeutique humaine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7818346A FR2429021A1 (fr) | 1978-06-20 | 1978-06-20 | Composition pharmaceutique utile dans le traitement de diverses maladies par action sur le systeme reticuloendothelial et application de cette composition au traitement de tumeurs malignes en therapeutique humaine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2429021A1 true FR2429021A1 (fr) | 1980-01-18 |
| FR2429021B1 FR2429021B1 (fr) | 1981-06-12 |
Family
ID=9209720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7818346A Granted FR2429021A1 (fr) | 1978-06-20 | 1978-06-20 | Composition pharmaceutique utile dans le traitement de diverses maladies par action sur le systeme reticuloendothelial et application de cette composition au traitement de tumeurs malignes en therapeutique humaine |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2429021A1 (fr) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0055118A1 (fr) * | 1980-12-19 | 1982-06-30 | Wallace Lysaght | Traitement de l'arthrite |
| WO1990012563A1 (fr) * | 1989-04-24 | 1990-11-01 | Board Of Regents, The University Of Texas System | Compositions et procedes d'amelioration des caracteristiques d'aspect, croissance, ou cicatrisation cosmetique de tissus |
-
1978
- 1978-06-20 FR FR7818346A patent/FR2429021A1/fr active Granted
Non-Patent Citations (1)
| Title |
|---|
| EXBK/69 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0055118A1 (fr) * | 1980-12-19 | 1982-06-30 | Wallace Lysaght | Traitement de l'arthrite |
| WO1990012563A1 (fr) * | 1989-04-24 | 1990-11-01 | Board Of Regents, The University Of Texas System | Compositions et procedes d'amelioration des caracteristiques d'aspect, croissance, ou cicatrisation cosmetique de tissus |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2429021B1 (fr) | 1981-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JOP20180046B1 (ar) | متراكبات قابلة للذوبان في الماء من حديد وكربوهيدرات، إنتاجها وأدوية تحتوي عليها | |
| EP0356435A4 (fr) | Composes et compositions anti-inflammatoires. | |
| CA2265547A1 (fr) | Methode de traitement des lesions endotheliales | |
| IL57717A0 (en) | Platinum-diamine complexes,a method for the preparation thereof,a method for the preparation of a medicine using such a platinum-diamine complex for the treatment of cancer,as well as a medicine thus formed | |
| HUT51594A (en) | Process for production of celates and their complexes containing ortolizating functional groups, compositions containing such active substances and process for production of conjugates consisting of one complex and linked to it antibody or fragment of antibody | |
| ES419619A1 (es) | Procedimiento para remineralizar una sub-superficie desmi- neralizada de un diente. | |
| ATE25238T1 (de) | Pharmazeutische zusammensetzungen zur behandlung von entzuendungen oder arthritis. | |
| FR2429021A1 (fr) | Composition pharmaceutique utile dans le traitement de diverses maladies par action sur le systeme reticuloendothelial et application de cette composition au traitement de tumeurs malignes en therapeutique humaine | |
| EP0281070A3 (fr) | Composé pharmaceutique pour le traitement du cancer | |
| EP0004680A3 (en) | Pharmaceutical compositions, method of inhibiting and of treating cancerous tumours, and a nonatetraenoic acid | |
| GB1520135A (en) | Rotary harrow | |
| GB2022998A (en) | Pharmaceutical composition for the treatment of neoplastic and other diseases | |
| ES8404693A1 (es) | Procedimiento de preparacion de nuevos amino-14 esteroides. | |
| ES408279A1 (es) | Procedimiento de fabricacion de la metilcobalamina por re- duccion y metilacion de la hidroxocobalamina. | |
| ES2188336A1 (es) | Aductos de albumina soluble con complejos polihidroxilados (polialcoholicos) de hierro trivalente, metodo de obtencion y preparaciones farmaceuticas y dieteticas que los contienen. | |
| JPS51149174A (en) | A fluid treatment process | |
| JPS5274568A (en) | Treating of exhaust liquid containing nutritious salts having nitrogen | |
| JUNG et al. | The effect of Helicobacter pylori eradication of triple therapy with omeprazole, amoxicillin and clarithromycin | |
| JPS51125758A (en) | A health promoting food | |
| KR790000562B1 (en) | Method of collecting urokinase | |
| JPS5265973A (en) | Process for treating water containing phosphate and sulfate ions | |
| FR2166349A1 (en) | Difeu alkaloids - for treating diarrhoea, peptic ulcer anorexia, as a diuretic, as a sclerosing agent | |
| FR2299294A1 (fr) | Composition solide d'engrais mixte soluble dans l'eau et son procede de fabrication | |
| ES362105A1 (es) | Un metodo para la produccion de composiciones menos irri- tantes al ponerlas en contacto con la piel humana. | |
| ES356078A1 (es) | Metodo de preparacion de compuestos complejos de hierro fe-rrico. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |